Abiraterone With Different Steroid Regimens for Side Effect Related to Mineralcorticoid Excess Prevention in Prostate Cancer Prior to Chemotherapy

NCT01867710 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

164

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Abiraterone Acetate
DRUG: Prednisone 5 mg twice daily
DRUG: Prednisone 5 mg once daily
DRUG: Prednisone 2.5 mg twice daily
DRUG: Dexamethasone 0.5 mg once daily

Sponsor

Janssen Pharmaceutica N.V., Belgium